课题基金 / 基金详情

OPIOID PEPTIDE PROCESSING ENZYMES

OPIOID PEPTIDE PROCESSING ENZYMES
阿片肽加工酶
批准号:
6174505
负责人:
IRIS LINDBERG
金额:
$11.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-30 至 2003-08-31

项目摘要

项目成果

IRIS LINDBERG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Applicant's Abstract): This renewal of a K02 award is requested in order to free the applicant from substantive teaching and administrative responsibilities to increase research productivity. During the past 4 years the PI has been able to devote more than 80% of her time to research activities, a level of effort which has resulted in a significantly enhanced ability to perform experiments, advise postdoctoral fellows and graduate students, and acquire new technologies both by collaboration as well as by hands-on experimentation. This enhancement of research effort is expected to continue during the renewal period of the application with the protection afforded by the K02 award; without it, teaching responsibilities are likely to increase dramatically, most notably by the assumption of course directorship in a major service course. The proposal is based upon two currently ongoing projects, one on the proteolytic processing of opioid peptide precursors, and one on the mechanism of action of the PC2 binding protein 7B2. The four specific aims are 1) to define the specificity of recombinant PC1 and PC2 using recombinant normal and mutant proenkephalins and related fluorogenic substrates; these experiments will delineate substrate preferences of the two PCs. 2) To identify novel PC1 inhibitors, study the biochemistry and cell biology of PC1 and PC2 inhibitors, and assess potential effects of targeted inhibitors on proenkephalin processing in vivo. These experiments will complement those described in the first specific aim as to enzyme specificity and should yield information on the design of synthetic enzyme inhibitors. 3) To determine the role of 7B2 in the regulation of proPC2 conversion in neuroendocrine cel1 lines, with a focus on the fate of the propeptide and the relationship of its cleavage/dissociation to that of 7B2 forms. 4) To explore the molecular interaction of 7B2 and PC2 through in vitro experiments. Taken together, these experiments should help us to understand the basic biochemistry of the prohormone convertases on opioid peptide precursors as well as the regulation of convertase activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
  • 批准号:
    10327703
  • 项目类别:
  • 资助金额:
    $63.37万
  • 财政年份:
    2019
  • 负责人:
    IRIS LINDBERG
  • 依托单位:
ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
  • 批准号:
    10532769
  • 项目类别:
  • 资助金额:
    $63.37万
  • 财政年份:
    2019
  • 负责人:
    IRIS LINDBERG
  • 依托单位:
ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
  • 批准号:
    10062465
  • 项目类别:
  • 资助金额:
    $63.37万
  • 财政年份:
    2019
  • 负责人:
    IRIS LINDBERG
  • 依托单位:
Opioid Peptide Synthesizing Enzymes
  • 批准号:
    10163827
  • 项目类别:
  • 资助金额:
    $34.5万
  • 财政年份:
    2017
  • 负责人:
    IRIS LINDBERG
  • 依托单位:
海外基金